SCHEMBL7988149

SCHEMBL7988149

CC(C)OCCn1c(NC2CCN(C(=O)OC(C)(C)C)CC2)nc2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
MAPT P10636 2/20 0.48
MAPK1 P28482 2/20 0.48
NPC1 O15118 1/20 0.48
HTT P42858 1/20 0.48
RAB9A P51151 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KCNH2 Q12809 4/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
OPRM1 P35372 1/20 0.44
OPRD1 P41143 1/20 0.44
OGFRL1 Q5TC84 1/20 0.44
GPR119 Q8TDV5 2/20 0.43
BRD4 O60885 1/20 0.43
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
ATM Q13315 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7982292 0.88 ALDH1A1 (0.47) ALDH1A1MAPTMAPK1NPC1HTT
SCHEMBL6993631 0.85 KCNH2 (0.47) ALDH1A1MAPTMAPK1NPC1HTT
SCHEMBL5007368 0.84 ALDH1A1 (0.53) ALDH1A1MAPTMAPK1NPC1HTT
SCHEMBL3870704 0.82 ALDH1A1 (0.48) ALDH1A1MAPTMAPK1NPC1HTT
SCHEMBL3876509 0.82 SMN1; SMN2 (0.50) ALDH1A1MAPTMAPK1NPC1HTT
SCHEMBL7988314 0.82 ALDH1A1 (0.48) ALDH1A1MAPTMAPK1KCNH2LMNA
SCHEMBL7984810 0.81 ALDH1A1 (0.51) ALDH1A1MAPTMAPK1NPC1HTT
SCHEMBL6997081 0.81 ALDH1A1 (0.52) ALDH1A1MAPTMAPK1NPC1HTT
SCHEMBL3870711 0.81 ALDH1A1 (0.46) ALDH1A1MAPTMAPK1NPC1HTT
SCHEMBL5125428 0.80 ALDH1A1 (0.49) ALDH1A1MAPTMAPK1NPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211199-B1 HISTAMINE AND TACHYKININ RECEPTOR ANTAGONISTS; ANTIASTHMATICS, ANTIEMETICS; RESPIRATORY SYSTEM DISORDERS, INFLAMMATORY BOWEL DISEASE, CONJUNCTIVITIS AVENTIS PHARMACEUTICALS INC. 2001-04-03 US disclosed